Shenzhen CrystalO Biopharma Technology Co., Ltd.
PrivateLast Round
Pre Seed
Mar 13, 2020
Total Funding Raised
$3.29M
Company Overview
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a biotechnology company that specializes in the research and development of innovative ion channel medicines for neurological, psychiatric, chronic kidney, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Comparables
Compare Shenzhen CrystalO Biopharma Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| leadXpro AG | 81% | |
| Ligand Pharmaceuticals | 77% | |
| Abilita Therapeutics | 76% |
Shenzhen CrystalO Biopharma Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 13, 2020 | ||||
| Early Funding | Apr 15, 2019 | ||||
| Angel | Nov 27, 2018 |
Shenzhen CrystalO Biopharma Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CAS Star | Pre Seed, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2020
$2.86M round led by CAS Star
- Apr 15, 2019
Company raised an early funding round.
Recent news
Latest coverage and updates
- is_developingAug 10, 2026
Crystalobio is developing innovative drug candidates for skin diseases on Aug 10th '26.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenzhen CrystalO Biopharma Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen CrystalO Biopharma Technology Co., Ltd. a public or private company?
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a private company.
What is the current stock price of Shenzhen CrystalO Biopharma Technology Co., Ltd.?
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Shenzhen CrystalO Biopharma Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shenzhen CrystalO Biopharma Technology Co., Ltd. worth (valuation)?
Valuation information for Shenzhen CrystalO Biopharma Technology Co., Ltd. is not publicly available.
Can I buy Shenzhen CrystalO Biopharma Technology Co., Ltd. stock?
Shenzhen CrystalO Biopharma Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenzhen CrystalO Biopharma Technology Co., Ltd.'s last funding round?
Shenzhen CrystalO Biopharma Technology Co., Ltd.'s most recent funding round was Pre Seed on March 13, 2020.
Who are the main investors in Shenzhen CrystalO Biopharma Technology Co., Ltd.?
Key investors in Shenzhen CrystalO Biopharma Technology Co., Ltd. include CAS Star.
Will Shenzhen CrystalO Biopharma Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen CrystalO Biopharma Technology Co., Ltd..
How can I track Shenzhen CrystalO Biopharma Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenzhen CrystalO Biopharma Technology Co., Ltd.'s secondary market activity and sign up for updates.